Aytu Biopharma (AYTU) Inventory (2015 - 2026)

Aytu Biopharma (AYTU) has reported Inventory for 12 consecutive years, with $7.5 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Inventory fell 32.54% year-over-year to $7.5 million in Q1 2026; TTM through Mar 2026 was $7.5 million, a 32.54% decrease from a year earlier, with the FY2025 full-year figure at $11.4 million, down 5.82% from the prior year.
• Inventory was $7.5 million for Q1 2026 at Aytu Biopharma, down from $8.7 million in the prior quarter.
• Over five years, Inventory peaked at $13.9 million in Q1 2022 and troughed at $7.5 million in Q1 2026.
• A 5-year average of $11.7 million and a median of $12.0 million in 2023 frame the typical range for Inventory.
• Across the five-year window, Inventory plunged 33.6% in 2022 and climbed 10.56% in 2023, its largest moves.
• Over 5 years, Inventory stood at $13.0 million in 2022, then gained by 0.39% to $13.0 million in 2023, then fell by 14.74% to $11.1 million in 2024, then fell by 21.91% to $8.7 million in 2025, then fell by 13.82% to $7.5 million in 2026.
• The last three Inventory figures came in at $7.5 million (Q1 2026), $8.7 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.